Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.11 USD | +0.77% | +1.48% | -41.05% |
Mar. 05 | Transcript : Semler Scientific, Inc., Q4 2023 Earnings Call, Mar 05, 2024 | |
Mar. 05 | Earnings Flash (SMLR) SEMLER SCIENTIFIC Posts Q4 Revenue $15.1M, vs. Street Est of $14.5M | MT |
Financials (USD)
Sales 2024 * | 75.5M | Sales 2025 * | - | Capitalization | 184M |
---|---|---|---|---|---|
Net income 2024 * | 26M | Net income 2025 * | - | EV / Sales 2024 * | 2.43 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
7.68
x | P/E ratio 2025 * |
-
| Employees | 92 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.47% |
Latest transcript on Semler Scientific, Inc.
1 day | +0.77% | ||
1 week | +1.48% | ||
Current month | -10.61% | ||
1 month | -8.13% | ||
3 months | -40.66% | ||
6 months | -9.87% | ||
Current year | -41.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 12-08-31 | |
Renae Cormier
DFI | Director of Finance/CFO | 52 | 22-04-30 |
Chief Operating Officer | - | 10-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
H. Semler
CHM | Chairman | 59 | 23-04-18 |
Daniel Messina
BRD | Director/Board Member | 68 | 20-08-12 |
Chief Executive Officer | 70 | 12-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 27 M€ | -5.03% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 26.11 | +0.77% | 30,272 |
24-04-25 | 25.91 | -2.67% | 52,030 |
24-04-24 | 26.62 | -1.73% | 47,993 |
24-04-23 | 27.09 | +3.16% | 70,536 |
24-04-22 | 26.26 | +2.06% | 39,868 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.05% | 184M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.01B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- SMLR Stock